Watkins Tim
Contineum Therapeutics, Inc. Class A Common Stock · CMO & Head of Development
Watkins Tim is listed in public filings as officer: CMO & Head of Development. This Watkins Tim insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Contineum Therapeutics, Inc. Class A Common Stock (CTNM). Investors use Watkins Tim's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $03.6k shares | SellMar 2, 2026 | $54.2K3.6k shares | $15.02 | -- | |
| $16k3.6k shares | Grant / ExerciseMar 2, 2026 | $16.3K3.6k shares | $4.50 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.3M160k shares | Grant / ExerciseJan 30, 2026 | $2.3M160k shares | $14.26 | -- | |
| $11k811 shares | SellJan 28, 2026 | $39.4K2.8k shares | $14.09 | -- | |
| $16k3.6k shares | Grant / ExerciseJan 28, 2026 | $16.3K3.6k shares | $4.50 | -- | |
| $0811 shares | SellJan 28, 2026 | $11.7K811 shares | $14.48 | -- | |
| $03.6k shares | SellDec 29, 2025 | $43.6K3.6k shares | $12.06 | -- | |
| $16k3.6k shares | Grant / ExerciseDec 29, 2025 | $16.3K3.6k shares | $4.50 | -- | |
| $1.2M260k shares | Grant / ExerciseApr 28, 2025 | $1.2M260k shares | $4.50 | -- | |
| $117k26k shares | Grant / ExerciseApr 28, 2025 | $117.0K26k shares | $4.50 | -- |